Atlantic Coastal Acquisition Corp. II (ACAB) Competitors $5.77 -5.13 (-47.06%) (As of 11/12/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends ACAB vs. HRTX, CABA, MDWD, DMAC, GOSS, LFVN, ATOS, GALT, CKPT, and SCPHShould you be buying Atlantic Coastal Acquisition Corp. II stock or one of its competitors? The main competitors of Atlantic Coastal Acquisition Corp. II include Heron Therapeutics (HRTX), Cabaletta Bio (CABA), MediWound (MDWD), DiaMedica Therapeutics (DMAC), Gossamer Bio (GOSS), LifeVantage (LFVN), Atossa Therapeutics (ATOS), Galectin Therapeutics (GALT), Checkpoint Therapeutics (CKPT), and scPharmaceuticals (SCPH). These companies are all part of the "pharmaceutical products" industry. Atlantic Coastal Acquisition Corp. II vs. Heron Therapeutics Cabaletta Bio MediWound DiaMedica Therapeutics Gossamer Bio LifeVantage Atossa Therapeutics Galectin Therapeutics Checkpoint Therapeutics scPharmaceuticals Heron Therapeutics (NASDAQ:HRTX) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACAB) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, community ranking, risk, earnings, institutional ownership, media sentiment, profitability, valuation and analyst recommendations. Which has stronger earnings and valuation, HRTX or ACAB? Atlantic Coastal Acquisition Corp. II has lower revenue, but higher earnings than Heron Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHeron Therapeutics$127.04M1.48-$110.56M-$0.18-6.89Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A Does the media refer more to HRTX or ACAB? In the previous week, Heron Therapeutics had 12 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 16 mentions for Heron Therapeutics and 4 mentions for Atlantic Coastal Acquisition Corp. II. Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.94 beat Heron Therapeutics' score of 0.35 indicating that Atlantic Coastal Acquisition Corp. II is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Heron Therapeutics 1 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Atlantic Coastal Acquisition Corp. II 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor HRTX or ACAB? Heron Therapeutics received 662 more outperform votes than Atlantic Coastal Acquisition Corp. II when rated by MarketBeat users. CompanyUnderperformOutperformHeron TherapeuticsOutperform Votes66269.17% Underperform Votes29530.83% Atlantic Coastal Acquisition Corp. IIN/AN/A Do institutionals & insiders have more ownership in HRTX or ACAB? 80.0% of Heron Therapeutics shares are owned by institutional investors. Comparatively, 23.3% of Atlantic Coastal Acquisition Corp. II shares are owned by institutional investors. 5.8% of Heron Therapeutics shares are owned by insiders. Comparatively, 91.2% of Atlantic Coastal Acquisition Corp. II shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is HRTX or ACAB more profitable? Atlantic Coastal Acquisition Corp. II has a net margin of 0.00% compared to Heron Therapeutics' net margin of -20.31%. Company Net Margins Return on Equity Return on Assets Heron Therapeutics-20.31% N/A -12.74% Atlantic Coastal Acquisition Corp. II N/A N/A N/A Do analysts rate HRTX or ACAB? Heron Therapeutics currently has a consensus target price of $5.67, indicating a potential upside of 356.99%. Given Heron Therapeutics' stronger consensus rating and higher possible upside, equities research analysts plainly believe Heron Therapeutics is more favorable than Atlantic Coastal Acquisition Corp. II.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Heron Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Atlantic Coastal Acquisition Corp. II 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility and risk, HRTX or ACAB? Heron Therapeutics has a beta of 1.81, meaning that its share price is 81% more volatile than the S&P 500. Comparatively, Atlantic Coastal Acquisition Corp. II has a beta of 0.01, meaning that its share price is 99% less volatile than the S&P 500. SummaryHeron Therapeutics beats Atlantic Coastal Acquisition Corp. II on 8 of the 12 factors compared between the two stocks. Ad Porter & CompanyElon Musk has put himself in their crosshairsToday, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.I share with you in this special investigative documentary. Get Atlantic Coastal Acquisition Corp. II News Delivered to You Automatically Sign up to receive the latest news and ratings for ACAB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACAB vs. The Competition Export to ExcelMetricAtlantic Coastal Acquisition Corp. IIHolding Offices IndustryUnclassified SectorNASDAQ ExchangeMarket Cap$47.14M$265.06M$108.08M$8.88BDividend YieldN/A7.76%5.19%4.04%P/E RatioN/A9.609.2917.45Price / SalesN/A112.471.5398.78Price / CashN/A76.6496.8236.42Price / BookN/A78.27519.875.86Net IncomeN/A$33.63M$2.80M$224.86M7 Day Performance-42.76%-1.57%-1.37%-0.93%1 Month Performance-48.02%-3.04%-2.40%3.66%1 Year Performance-45.57%12.81%16.67%26.41% Atlantic Coastal Acquisition Corp. II Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACABAtlantic Coastal Acquisition Corp. IIN/A$5.77-47.1%N/A-45.5%$47.14MN/A0.004Short Interest ↑News CoverageHigh Trading VolumeHRTXHeron Therapeutics4.0609 of 5 stars$1.24+2.5%$5.67+357.0%+121.7%$188.07M$127.04M-6.89300Earnings ReportAnalyst ForecastShort Interest ↓News CoverageCABACabaletta Bio2.0978 of 5 stars$3.78-5.7%$28.10+643.4%-77.0%$184.65MN/A-1.9950MDWDMediWound2.0375 of 5 stars$16.37-1.4%$29.00+77.2%+109.6%$176.63M$18.69M-7.5880Positive NewsDMACDiaMedica Therapeutics2.2028 of 5 stars$4.12-3.3%$7.00+69.9%+82.1%$176.12MN/A-7.7720News CoverageGOSSGossamer Bio4.5044 of 5 stars$0.77-5.6%$9.20+1,094.8%+29.5%$174.48MN/A-2.41180Earnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionNews CoverageLFVNLifeVantage3.3491 of 5 stars$13.81-2.7%N/A+224.0%$172.90M$200.16M43.16260Positive NewsHigh Trading VolumeATOSAtossa Therapeutics1.4117 of 5 stars$1.37flat$6.75+392.7%+117.0%$172.29MN/A-6.238Analyst ForecastNews CoverageGALTGalectin Therapeutics2.1017 of 5 stars$2.75-5.2%$11.00+300.0%+48.7%$171.27MN/A-3.489Analyst DowngradeNews CoveragePositive NewsGap UpCKPTCheckpoint Therapeutics3.6257 of 5 stars$3.78+4.4%$12.00+217.5%+100.0%$170.17M$78,000.00-2.0510Earnings ReportAnalyst ForecastHigh Trading VolumeSCPHscPharmaceuticals4.0474 of 5 stars$3.36-14.1%$15.00+346.4%-21.5%$168.10M$24.05M-2.1530Analyst ForecastNews CoverageGap DownHigh Trading Volume Related Companies and Tools Related Companies HRTX Alternatives CABA Alternatives MDWD Alternatives DMAC Alternatives GOSS Alternatives LFVN Alternatives ATOS Alternatives GALT Alternatives CKPT Alternatives SCPH Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ACAB) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThis small cap’s electric marine powertrain broke the world speed recordThe future of marine propulsion has arrived-powered by a $2 billion powerhouse. In collaboration with McLar...The Tomorrow Investor | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredThe next assassination attempt won’t be on TrumpPresident Trump is soon to be back in the White House. Unity has been restored to the U.S. But if you wa...Porter & Company | SponsoredElon Musk’s $30 Billion Trump Bet Pays Off—What’s Next?Elon Musk bet big on Trump's victory, and that gamble has already added over $30 billion to his net worth in a...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atlantic Coastal Acquisition Corp. II Please log in to your account or sign up in order to add this asset to your watchlist. Share Atlantic Coastal Acquisition Corp. II With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
